Parkinson's Disease Global Clinical Trials Review, H2, 2013

Date: October 31, 2013
Pages: 151
Price:
US$ 2,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PC01154E96AEN
Leaflet:

Download PDF Leaflet

Parkinson's Disease Global Clinical Trials Review, H2, 2013
Parkinson's Disease Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, “Parkinson's Disease Global Clinical Trials Review, H2, 2013' provides data on the Parkinson’s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Parkinson’s Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Parkinson’s Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Parkinson's Disease
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Parkinson's Disease
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Parkinson's Disease Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
C. H. Boehringer Sohn AG & Co. KG
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
UCB S.A.
Clinical Trial Overview of UCB S.A.
Novartis AG
Clinical Trial Overview of Novartis AG
Teva Pharmaceutical Industries Limited
Clinical Trial Overview of Teva Pharmaceutical Industries Limited
AbbVie Inc.
Clinical Trial Overview of AbbVie Inc.
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
H. Lundbeck A/S
Clinical Trial Overview of H. Lundbeck A/S
Kirin Holdings Company, Limited
Clinical Trial Overview of Kirin Holdings Company, Limited
Eisai Co., Ltd.
Clinical Trial Overview of Eisai Co., Ltd.
Bial - Portela & Ca, S.A.
Clinical Trial Overview of Bial - Portela & Ca, S.A.
Clinical Trial Overview of Top Institutes / Government
National Institute of Neurological Disorders and Stroke
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
U.S. Department of Veterans Affairs
Clinical Trial Overview of U.S. Department of Veterans Affairs
Oregon Health and Science University
Clinical Trial Overview of Oregon Health and Science University
Institute for Neurodegenerative Disorders
Clinical Trial Overview of Institute for Neurodegenerative Disorders
Radboud University
Clinical Trial Overview of Radboud University
Washington University School of Medicine
Clinical Trial Overview of Washington University School of Medicine
Tel-Aviv Sourasky Medical Center
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center
UNIVERSITY HOSPITAL, CLERMONT-FERRAND
Clinical Trial Overview of UNIVERSITY HOSPITAL, CLERMONT-FERRAND
University of Rochester
Clinical Trial Overview of University of Rochester
University Hospital, Toulouse
Clinical Trial Overview of University Hospital, Toulouse
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Zone, 2013
Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2013
Parkinson's Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013
Parkinson's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013
Parkinson's Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2013
Parkinson's Disease Therapeutics Clinical Trials, North America, Top Countries, 2013
Parkinson's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013
Parkinson's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013
Parkinson's Disease Therapeutics Clinical Trials, BRIC Countries, 2013
Parkinson's Disease Therapeutics Clinical Trials, G7 Countries, 2013
Parkinson's Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013
Parkinson's Disease Therapeutics Clinical Trials, E7 Countries, 2013
Parkinson's Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013
Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Phase, 2013
Parkinson's Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013
Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2013
Parkinson's Disease Therapeutics Market, Global, Suspended Clinical Trials, 2013
Parkinson's Disease Therapeutics Market, Global, Withdrawn Clinical Trials, 2013
Parkinson's Disease Therapeutics Market, Global, Terminated Clinical Trials, 2013
Parkinson's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
Parkinson's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2013
Parkinson's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013
Parkinson's Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lundbeck A/S, 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kirin Holdings Company, Limited, 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Bial - Portela & Ca, S.A., 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute for Neurodegenerative Disorders, 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by UNIVERSITY HOSPITAL, CLERMONT-FERRAND, 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2013
Parkinson's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2013

LIST OF FIGURES

Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2013
Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2013
Parkinson's Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013
Parkinson's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013
Parkinson's Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013
Parkinson's Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2013
Parkinson's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013
Parkinson's Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013
Parkinson's Disease Therapeutics Clinical Trials, BRIC Countries (%), 2013
Parkinson's Disease Therapeutics Clinical Trials, G7 Countries (%), 2013
Parkinson's Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013
Parkinson's Disease Therapeutics Clinical Trials, E7 Countries (%), 2013
Parkinson's Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013
Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2013
Parkinson's Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013
Parkinson's Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2013
Parkinson's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
Parkinson's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2013
Parkinson's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013
Parkinson's Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013
GlobalData Methodology

Ask Your Question

Parkinson's Disease Global Clinical Trials Review, H2, 2013
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: